CLINICAL ROLE -
Future Studies and Implications for Dupilumab in Atopic Dermatitis
Future studies are necessary to continue evaluating the true benefits of dupilumab in conditions like atopic dermatitis.
Watch
Daily Medication Pearl: Brimonidine Ophthalmic Solution (Alphagan P)
Brimonidine ophthalmic solution (Alphagan P) is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Read More
Pharmacy Clinical Pearl of the Day: Geographic Tongue
Treatment for geographic tongue includes OTC pay relievers, mouth rinses with anesthetics, antihistamines, corticosteroids, and vitamin B supplements.
Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant
Results from multiple studies show that the effectiveness of nirmatrelvir, the active main protease inhibitor of Paxlovid is maintained.
Maternal COVID-19 Infection Raises Risks of Low Birth Weight, Preterm Birth, and Stillbirth
Study results show that unvaccinated pregnant women with the disease are more likely to experience poor childbirth outcomes, even if they did not have severe respiratory problems.
Apremilast Shows Statistically Significant Improvements in Genital Psoriasis
Oral apremilast achieved a clinically meaningful and statistically significant improvement in the primary endpoint of the modified static Physician’s Global Assessment of Genitalia response.
The Real Reason Why COVID-19 is Exceedingly Difficult To Manage
Ending the COVID-19 pandemic requires an understanding of how to manage the inflammatory dysfunction that the virus causes.
FDA Approves Magnesium Sulfate Injection From Milla Pharmaceuticals
Agency green light could help get medication off ASHP drug shortage list by reducing supply issues.
Brukinsa From BeiGene, Ltd
The FDA has approved zanubrutinib (Brukinsa, BeiGene) for the treatment of adults with Waldenström macroglobulinemia (WM).
Shingles Vaccine Minimizes Costs, Complications of a Common Infection
After varicella zoster virus causes chickenpox, it remains dormant in the central nervous system and can later reactivate to cause shingles
Pembrolizumab Shows Improvements in Disease-Free Survival as Adjuvant Treatment for Non-Small Cell Lung Cancer
The findings from the phase 3 KEYNOTE-091 trial mark the first positive study for pembrolizumab in adjuvant stage IB-IIIA non-small cell lung cancer.
Daily OTC Pearl: Emetrol
Emetrol is used to treat an upset stomach and vomiting.
Daily Medication Pearl: Brimonidine Tartrate/Timolol (Combigan)
Combigan is comprised of 2 components that reduce elevated intraocular pressure, whether or not associated with glaucoma.
Pharmacy Focus Podcast: Pharmacy Tech Talk- Episode 4
Amy Summers, consultant at Restore Health Consulting, discusses the proposed changed to the USP 795 and 797.
Listen
Defining Value and Quality in Pharmacy
Evaluating the need to define and standardize how quality can be measured in pharmacy.
Pharmacy Clinical Pearl of the Day: Glaucoma
If glaucoma is recognized early, vision loss can be slowed or prevented.
FDA Approves MENTOR MemoryGel BOOST Breast Implant
Approximately 400,000 women undergo breast implant surgeries each year in the United States, and selecting an implant is an important and personal part of the process.
Ivermectin Rx for COVID-19: Insurance Coverage Does Not Match Evidence
Study results show health plans paid most of the drug costs, despite the lack of effect seen on COVID-19.
WHO Recommends 2 New Drugs to Treat Patients With COVID-19
The World Health Organization issues a strong recommendation for baricitinib and a conditional one for sotrovimab.
Trastuzumab Deruxtecan Granted FDA Priority Review for HER2-Positive Metastatic Breast Cancer
Trastuzumab deruxtecan is a HER2-directed antibody drug conjugate being developed by both AstraZeneca and Daiichi Sankyo.
Therapeutics Treat Patients Who Test Positive for COVID-19
Monoclonal antibodies and emerging agents may avert severe illness, especially for high-risk individuals.
FDA Approves Abrocitinib for Adults with Moderate to Severe Atopic Dermatitis
Across the trials, abrocitinib demonstrated a consistent safety profile and profound improvements in skin clearance, extent of disease, and severity.
Prototype Biomarker Could Distinguish Healthy, Disruptive Gut Microbiota
The Microbiome Health Index for post-Antibiotic dysbiosis was developed to improve the understanding of and manage the risks associated with antibiotic administration.
Ensure the Safe Use of Automated Dispensing Technology
Pharmacies should address situations in which multiple bottles of tablets are used to refill a cassette.
FDA Approves Solensia to Control Osteoarthritis Pain in Cats
The drug is the first and only injectable monoclonal antibody treatment for feline OA approved in the United States.
Study: Infants With Low-Risk Deliveries May Not Need Antibiotics At Birth
The findings could help clinicians tailor the use of early antibiotics in newborns because only infants deemed at risk for infection should receive antibiotics.
Daily OTC Pearl: Senna Plus
Senna Plus should cause a bowel movement within 6 to 12 hours among individuals who experience occasional constipation.
Pharmacist Medication Insights: Fostemsavir (Rukobia) for HIV
Fostemsavir (Rukobia) is indicated in combination with other antiretroviral medications in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection.
Daily Medication Pearl: Besifloxacin (Besivance)
Besifloxacin ophthalmic suspension (Besivance) is indicated for the treatment of bacterial conjunctivitis.
COVID-19 Vaccines Offer Lasting Protection, Study Results Show
A new analysis suggests that boosters can provide ongoing prevention of death and hospitalization.